Medications for OUD: Who Should Get What When? | February 7, 2019
Date of Presentation: February 7, 2019
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder ECHO Program
Keywords: #buprenorphine #mat #methadone #naltrexone
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other clinical variables when used for treating opioid use disorder.
Presenter Bio:
Dr. Jessica Gregg
Jessica Gregg, MD, PhD, is an Associate Professor of Medicine at Oregon Health and Science University. She received her undergraduate degree from Stanford University, her medical degree from the University of New Mexico, and her doctorate in medical anthropology from Emory University. She is board certified in internal medicine and addiction medicine. At OHSU, Dr. Gregg serves as the Director of the university’s addiction medicine ECHO clinics, as Associate Program Director for OHSU’s addiction medicine fellowship, and as Medical Director of the OHSU HRBR clinic, which provides low-barrier MAT to vulnerable adults. She also provides clinical care on IMPACT, OHSU’s inpatient addiction medical consult service.
Resource Provided:
Date added: February 7, 2019